Paid Clinical Trials in Fairway, KS
As of September 2026, 76 paid clinical trials are recruiting in Fairway, Kansas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Fairway offers studies at sites including University of Kansas Clinical Research Center for conditions such as Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Advanced Breast Cancer, Metastatic Malignant Solid Neoplasm. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Fairway
Trials by drug in Fairway
Filter results
Newly added in Fairway
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
73 clinical trials
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
SynKIR-310 for Relapsed/Refractory B-NHL
Study of ATX-01 in Participants With DM1
The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies
A Study of IBI363 in Subjects with Advanced Solid Malignancies
Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
Top Research Study Locations in Fairway
Researchers run research studies in Fairway, KS at 20 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Kansas Clinical Research Center | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Metastatic Malignant Solid Neoplasm | 30 |
| University of Kansas Medical Center | ASCVD, Advanced Breast Cancer, Alzheimer Disease | 7 |
| University of Kansas Cancer Center | ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML) | 6 |
| University of Kansas | Acute Myeloid Leukemia (AML), Advanced Breast Cancer, Advanced Solid Tumors | 5 |
| The University of Kansas Cancer Center | Advanced Breast Cancer, Advanced Solid Tumors With KRAS G12C Mutations, Aggressive B-Cell Non-Hodgkin Lymphoma | 4 |
| The University of Kansas Cancer Center (KUCC) | NSCLC Stage IV, Breast Cancer, Lung Cancer | 3 |
| The University of Kansas Clinical Research Center | Carcinoma, Non-Small Cell Lung, Cutaneous Squamous Cell Cancer, Esophageal Adenocarcinoma | 3 |
| Kansas University Medical Center | Acute Graft-versus-host Disease, Adverse Effects, Allogeneic Bone Marrow Transplantation | 2 |
| The University of Kansas - Clinical Research Center | Amyloid, Cognitive Dysfunction, Lewy Body Disease | 2 |
| University of Kansas Hospital | Alzheimer's Disease, Huntington Disease | 2 |
| GSK Investigational Site | Neoplasms, Solid Tumors | 1 |
| Kansas University Cancer Center | Advanced EGFR Positive Solid Tumor | 1 |
| Nkarta Investigational Site | Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, Idiopathic Inflammatory Myopathies, Rheumatoid Arthritis | 1 |
| The University of Kansas Cancer Center, Investigational Drug Services | Carcinoma, Non-Small Cell Lung, Cutaneous Squamous Cell Cancer, Esophageal Adenocarcinoma | 1 |
| The University of Kansas Hospital | Relapsed or Resistant Acute Leukaemias | 1 |
| The University of Kansas Medical Center Research Institute | AML With Mutated NPM1, Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent | 1 |
| US-Kansas City KS-KUMC | Acute Myeloid Leukemia, Adult | 1 |
| University of Kansas Hospital-Cancer Center | HER2-low Hormone Receptor Positive Breast Cancer, Melanoma (Skin Cancer) | 1 |
| University of Kansas Medical Center (KUMC) | Colorectal Cancer, Melanoma, Non-small Cell Lung Cancer | 1 |
| University of Kansas Medical Center, Department of Neurology | Myotonic Dystrophy 1 | 1 |
Active & Upcoming Studies in Fairway (2026)
Recruiting trials in Fairway grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (44 active studies)
- Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial) · Phase 2 · National Cancer Institute (NCI)
- Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene · Phase 1, Phase 2 · National Cancer Institute (NCI)
Neurology & pain (3 active studies)
- Testing the Effects of a Text Message Caregiver Support Intervention for Latinos · University of Kansas Medical Center
- Alzheimer's Disease Neuroimaging Initiative 4 · University of Southern California
Vaccines (1 active study)
- Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study · Phase 3 · Ansun Biopharma, Inc.
Pediatric (1 active study)
- Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors · Phase 1 · National Cancer Institute (NCI)
Common conditions studied in Fairway
- Acute Myeloid Leukemia (8 active studies)
- Stage IV Lung Cancer AJCC v8 (4 active studies)
- Advanced Breast Cancer (3 active studies)
- Metastatic Malignant Solid Neoplasm (3 active studies)
- Myelodysplastic Syndrome (3 active studies)
- Recurrent Lung Non-Small Cell Carcinoma (3 active studies)
Leading research sponsors in Fairway
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- University of Kansas Medical Center
- AstraZeneca
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Fairway?
There are approximately 76 recruiting clinical trials in Fairway, Kansas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Fairway pay participants?
Most recruiting trials in Fairway compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Fairway?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Fairway?
The most common conditions under active study in Fairway include Acute Myeloid Leukemia (8), Stage IV Lung Cancer AJCC v8 (4), Advanced Breast Cancer (3), Metastatic Malignant Solid Neoplasm (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Fairway?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Fairway on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Fairway?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Fairway?
Recruiting research sites in Fairway include University of Kansas Clinical Research Center, University of Kansas Medical Center, University of Kansas Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Fairway right now?
The largest active categories in Fairway are Cancer & tumors (44), Neurology & pain (3), Vaccines (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.